Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010

Royal Philips Electronics ( PHG, AEX: PHI), in partnership with the American College of Cardiology (ACC), spotlight the growing need for minimally-invasive interventions to address a spectrum of cardiac conditions, such as structural and degenerative heart issues.  The need to reduce invasive surgical interventions and complication rates is driving innovations in minimally invasive approaches.  Philips and ACC will jointly showcase the Hybrid OR Suite, a solution that combines in one room the equipment needed to perform both open and endovascular cardiac procedures.  Built out of combined efforts by Philips and its network of alliances, the Hybrid OR Suite will help advance how clinicians attend to patients in cardiac procedures.  The Hybrid OR Suite will be demonstrated at this year's annual meeting of the American College of Cardiology, March 14-16.

Traditionally, X-ray imaging is used to navigate cardiac interventions performed in a cardiac catheterization (cath) lab.  In recent times, importance has grown for 3D ultrasound imaging in visualizing complex structures during interventions.  A Hybrid OR Suite combines the sterility and instruments of a traditional operating room with the X-ray and ultrasound imaging systems and radiation shields of a cath lab.  

"Using live 3D TEE ultrasound, we can view the anatomy without incisions or surgery," said Roberto Lang, M.D., director of Noninvasive Cardiac Imaging Labs at the University of Chicago Medical Center.  "It provides 3D images unlike those from other technology, to help clinicians place therapeutic devices."

The cutting-edge Hybrid OR configuration not only provides hospitals with a room that is flexible enough to handle a wide variety of treatments and procedures, but it also helps clinicians from a variety of specialties to collaborate.  

"Multidisciplinary care is gaining broader acceptance as hospitals and healthcare institutions combine approaches and evolve in their delivery of cardiac care," said Henry Solomon, M.D., chief medical officer for business development at the American College of Cardiology.  "Rooms equipped to support both open surgical and minimally invasive endovascular approaches, such as the Hybrid OR, are designed to meet the specific needs of clinicians when they are called upon to perform difficult procedures."

The Hybrid OR Suite on display at this year's ACC is well-suited to enable clinicians to perform a full range of endovascular, percutaneous and open procedures.  Percutaneous procedures enable physicians to utilize minimally invasive catheter-based interventions to treat patients that may be too sick or frail for open interventions, such as in valve replacement surgery.

"The patient is happy, the procedure is less invasive and the collaboration between the cardiologist, the cardiac surgeons and industry -- with Philips providing the technology -- has made that possible," said Valluvan Jeevanandam, M.D., chief of Cardiac & Thoracic Surgery at the University of Chicago Medical Center.

Philips' Hybrid OR Suites are customized for customer needs and designed using an advanced 3D architectural planning tool that provides prospective customers with a visual rendering of possible room configurations.  From high-quality, high-resolution, multi-modality imaging with advanced 3D software to support confident decision-making, to surgical tables, lighting and other equipment considerations, the full scope of equipment combinations is assessed.

"Philips Healthcare is committed to improving patient outcomes by providing solutions to care providers that enable procedure evolutions and enhance collaboration amongst specialties to treat a wider patient population," said Joris van den Hurk, vice president of Cardiology Care Cycles for Philips Healthcare.  "Our developments in the Hybrid OR space, on display at ACC, illustrate these possibilities and also detail how best-of-breed technology providers can work together to foster patient-focused care."

SOURCE Philips Healthcare

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Philips Healthcare. (2018, July 27). Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20100312/Royal-Philips-Electronics-ACC-to-present-Hybrid-OR-Suite-designed-for-cardiac-procedures-at-ACC-2010.aspx.

  • MLA

    Philips Healthcare. "Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20100312/Royal-Philips-Electronics-ACC-to-present-Hybrid-OR-Suite-designed-for-cardiac-procedures-at-ACC-2010.aspx>.

  • Chicago

    Philips Healthcare. "Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010". News-Medical. https://www.news-medical.net/news/20100312/Royal-Philips-Electronics-ACC-to-present-Hybrid-OR-Suite-designed-for-cardiac-procedures-at-ACC-2010.aspx. (accessed November 21, 2024).

  • Harvard

    Philips Healthcare. 2018. Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20100312/Royal-Philips-Electronics-ACC-to-present-Hybrid-OR-Suite-designed-for-cardiac-procedures-at-ACC-2010.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Philips introduces new web-based informatics platform to hasten drug research and biomarker discovery